BPC-157 TB-500 10mg/10mg lyophilized research peptide blend vial
BPC-157 / TB-500 10mg / 10mg

$126.00

Add to cart

BPC-157 / TB-500 10mg / 10mg

$126.00

BPC-157 TB-500 is a dual-component lyophilized research blend supplying a stable pentadecapeptide alongside an actin-binding thymosin fragment at 10mg each, prepared for comparative peptide-interaction work in controlled laboratory settings.

BPC-157 TB-500 10mg / 10mg Research Peptide Blend

BPC-157 TB-500 pairs two structurally unrelated research peptides in a single lyophilized preparation, each labeled at 10mg. BPC-157 is a synthetic pentadecapeptide corresponding to a partial sequence of a protein isolated from gastric juice, and is noted in the literature for unusual stability in acidic conditions. TB-500 is a synthetic fragment of thymosin beta-4, a small actin-sequestering protein present in most mammalian cell types.

Why the two are studied together

The pairing is of interest precisely because the two components act through different mechanistic vocabularies. Thymosin beta-4 fragments are examined largely through the lens of actin binding and cytoskeletal dynamics, while BPC-157 appears in literature concerned with cytoprotection and angiogenic signaling. Supplying both at a matched 10mg label strength lets a research group hold concentration constant across arms and vary only the variable under test.

Common investigational contexts include comparative peptide-interaction models, cytoskeletal assembly assays, and structure-function analysis where a short synthetic sequence is compared against a fragment of a larger native protein. The matched labeling also suits method-development work, where a laboratory is establishing detection or separation protocols and benefits from two distinct analytes in known proportion.

Specifications

  • Components: BPC-157 and TB-500
  • Label strength: 10mg / 10mg
  • Format: Lyophilized powder, single vial
  • Presentation: Dual-component research blend
  • Intended use: Laboratory research only

Storage and handling

Supplied as a lyophilized powder. Store sealed and protected from light, moisture and heat. Lyophilized peptide preparations are considerably more stable than solutions, so material is best held in its dry state until the point of use. Record lot identifiers on receipt — the two-component labeling makes lot-specific traceability particularly relevant where results are compared across batches.

This listing is provided for research identification and catalog organization. It describes composition and label strength only, and makes no clinical, diagnostic, therapeutic or usage claims of any kind.

Research Use Only: This product is sold strictly for laboratory research purposes. Not for human or veterinary use. Not for diagnostic, therapeutic, food, cosmetic, or household applications.

FDA Disclaimer: The statements on this website have not been evaluated by the U.S. Food and Drug Administration. The products and information provided by Vepra Peptides are not intended to diagnose, treat, cure, or prevent any disease.

Vepra Peptides is a research chemical supplier. We are not a compounding pharmacy or compounding facility as defined under Section 503A of the Federal Food, Drug, and Cosmetic Act, nor are we an outsourcing facility as defined under Section 503B.

All products are sold for research, laboratory, or analytical purposes only, and are NOT for human consumption. All sales are final. Customers are responsible for compliance with all applicable laws.